These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8522026)

  • 21. Recognition and treatment of salivary induced conditions.
    Sreebny LM
    Int Dent J; 1989 Sep; 39(3):197-204. PubMed ID: 2676866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of salivary substitutes versus a natural sialogogue (citric acid) in patients complaining of dry mouth as an adverse drug reaction: a clinical, randomized controlled study.
    Femiano F; Rullo R; di Spirito F; Lanza A; Festa VM; Cirillo N
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jul; 112(1):e15-20. PubMed ID: 21507689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of a saliva substitute in postradiation xerostomic patients.
    Ownby HE
    Ky Dent J; 1982; 34(6):19-20, 22-4. PubMed ID: 6960211
    [No Abstract]   [Full Text] [Related]  

  • 24. Dry mouth and salivary gland hypofunction, Part III: Treatment.
    Sreebny LM
    Compendium; 1988 Oct; 9(9):716-7, 720-1. PubMed ID: 3248291
    [No Abstract]   [Full Text] [Related]  

  • 25. Salivary gland dysfunction and xerostomia in Sjögren's syndrome.
    Jensen SB; Vissink A
    Oral Maxillofac Surg Clin North Am; 2014 Feb; 26(1):35-53. PubMed ID: 24287192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xerostomia: diagnosis and management.
    Greenspan D
    Oncology (Williston Park); 1996 Mar; 10(3 Suppl):7-11. PubMed ID: 8723427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Saliva substitute in xerostomic patients with primary Sjögren's syndrome: a single-blind trial.
    Alves MB; Motta AC; Messina WC; Migliari DA
    Quintessence Int; 2004 May; 35(5):392-6. PubMed ID: 15130080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the effectiveness of a chamomile (Matricaria chamomilla) and linseed (Linum usitatissimum) saliva substitute in the relief of xerostomia in elders.
    Morales-Bozo I; Ortega-Pinto A; Rojas Alcayaga G; Aitken Saavedra JP; Salinas Flores O; Lefimil Puente C; Lozano Moraga C; Manríquez Urbina JM; Urzúa Orellana B
    Gerodontology; 2017 Mar; 34(1):42-48. PubMed ID: 26763612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of oral moisturizing jelly as a saliva substitute for the relief of xerostomia in elderly patients with hypertension and diabetes mellitus.
    Dalodom S; Lam-Ubol A; Jeanmaneechotechai S; Takamfoo L; Intachai W; Duangchada K; Hongsachum B; Kanjanatiwat P; Vacharotayangul P; Trachootham D
    Geriatr Nurs; 2016; 37(2):101-9. PubMed ID: 26631691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of a synthetic polymer saliva substitute in reducing oral complaints of patients suffering from irradiation-induced xerostomia.
    Regelink G; Vissink A; Reintsema H; Nauta JM
    Quintessence Int; 1998 Jun; 29(6):383-8. PubMed ID: 9728149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An update of the etiology and management of xerostomia.
    Porter SR; Scully C; Hegarty AM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Jan; 97(1):28-46. PubMed ID: 14716254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Oral dryness in geriatric patients].
    Hockers T; Lamy M
    Rev Belge Med Dent (1984); 1999; 54(1):41-50. PubMed ID: 10876716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of artificial saliva and pilocarpine in the management of xerostomia in patients with advanced cancer.
    Davies AN; Daniels C; Pugh R; Sharma K
    Palliat Med; 1998 Mar; 12(2):105-11. PubMed ID: 9616446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a combined polymer system for use in relieving the symptoms of xerostomia.
    Corcoran RA; Stovell AG; Urquhart D; Chui T; Richardson M
    J Clin Dent; 2006; 17(2):34-8. PubMed ID: 16898429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of a new oral lubricant solution in the management of psychotropic drug-induced xerostomia: a randomized controlled trial.
    Mouly SJ; Orler JB; Tillet Y; Coudert AC; Oberli F; Preshaw P; Bergmann JF
    J Clin Psychopharmacol; 2007 Oct; 27(5):437-43. PubMed ID: 17873673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug induced xerostomia. The effects and treatment.
    Grad H; Grushka M; Yanover L
    J Can Dent Assoc; 1985 Apr; 51(4):296-300. PubMed ID: 3891040
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of xerostomia with the bile secretion-stimulating drug anethole trithione: a clinical trial.
    Hamada T; Nakane T; Kimura T; Arisawa K; Yoneda K; Yamamoto T; Osaki T
    Am J Med Sci; 1999 Sep; 318(3):146-51. PubMed ID: 10487404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of saliva substitutes in patients with xerostomia].
    Meyer-Lueckel H; Kielbassa AM
    Schweiz Monatsschr Zahnmed; 2002; 112(10):1037-58. PubMed ID: 12442709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials.
    Rieke JW; Hafermann MD; Johnson JT; LeVeque FG; Iwamoto R; Steiger BW; Muscoplat C; Gallagher SC
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):661-9. PubMed ID: 7852133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of Xialine in patients with xerostomia resulting from radiotherapy for head and neck cancer: a pilot-study.
    Jellema AP; Langendijk H; Bergenhenegouwen L; van der Reijden W; Leemans R; Smeele L; Slotman BJ
    Radiother Oncol; 2001 May; 59(2):157-60. PubMed ID: 11325444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.